On this page
Cantú syndrome
This syndrome is typically present from birth and can affect various parts of the body, including the heart, making early diagnosis and ongoing care important. It is caused by changes in certain genes and affects individuals from infancy.
Overview
Cantú syndrome is a rare genetic disorder that impacts multiple body systems, including the heart, bones, and facial features [PMID:22634354]. It is typically noticeable at birth or in early infancy. Individuals with Cantú syndrome often have a distinctive appearance, enlarged hearts, and skeletal abnormalities. The condition is caused by specific genetic changes that affect how certain channels in cells function, leading to a range of clinical signs that vary in severity among affected individuals [PMID:22634354]. Due to its rarity, the exact prevalence of Cantú syndrome is not well established.
Symptoms & clinical features
The symptoms of Cantú syndrome can be diverse and may affect different bodily systems. Common features include an enlarged heart (cardiomegaly), often due to ventricular hypertrophy, and a condition called patent ductus arteriosus (PDA), where a blood vessel connecting the aorta and pulmonary artery does not close after birth [PMID:22634354]. Skeletal abnormalities are also frequent, such as bone overgrowth, particularly affecting the long bones, and rib anomalies. Additionally, individuals may have hypertrichosis (excessive hair growth on the body and face) and characteristic facial features, which can include a broad nasal bridge and a wide mouth. Other potential signs can involve issues with blood pressure regulation, including low blood pressure (hypotension), and lymphoedema, which is swelling caused by fluid retention due to a compromised lymphatic system. Some individuals may also experience developmental delays, though the severity of these can vary significantly [PMID:23707164].
Video: Genetics 101
Affected organs
Cantú syndrome primarily affects the cardiovascular system, leading to abnormalities such as an enlarged heart and persistence of the patent ductus arteriosus. The skeletal system is also commonly involved, with features like increased bone density, bone overgrowth, and various rib anomalies [PMID:22634354]. The lymphatic system can be impacted, which may lead to lymphoedema. While the brain is not always directly affected pathologically, developmental delays have been observed in some individuals, suggesting potential neurological involvement.
Risks & severity
The severity of Cantú syndrome can vary widely between individuals, even within the same family. Clinical features can range from mild, requiring minimal intervention, to severe, needing extensive medical support, especially for cardiac issues. The main risks are associated with the cardiac abnormalities, such as heart enlargement, which can pose significant health challenges. While specific lifetime risks are difficult to quantify due to the condition's rarity, careful monitoring of cardiac function is generally recommended from an early age. The condition is typically congenital, meaning signs are often present at birth or manifest during infancy. Ongoing medical supervision is usually required throughout life to manage symptoms and address any complications as they arise.
Genetic causes
Cantú syndrome is caused by pathogenic variants in either the ABCC9 or KCNJ8 genes. These genes provide instructions for making proteins that are components of ATP-sensitive potassium (KATP) channels. These channels are crucial for regulating various cellular processes, including electrical activity in the heart and smooth muscle function in blood vessels. When a pathogenic variant occurs in ABCC9 or KCNJ8, it can lead to the KATP channels being constantly open or overactive. This improper functioning disrupts the normal cellular balance and contributes to the characteristic features seen in Cantú syndrome, such as cardiac enlargement, blood pressure regulation issues, and bone overgrowth [PMID:22634354]. Research indicates that the specific variant can influence the clinical presentation of the syndrome.
- ABCC9 ATP binding cassette subfamily C member 9
- KCNJ8 potassium inwardly rectifying channel subfamily J member 8
Inheritance pattern
Cantú syndrome is inherited in an autosomal dominant pattern. This means that a person needs only one copy of the altered gene to develop the condition. If a parent has Cantú syndrome, there is a 50% chance for each child they have to inherit the condition. In many cases, however, the genetic change occurs spontaneously in the affected individual and is not inherited from either parent; this is known as a de novo variant. For individuals with a de novo variant, their parents typically do not carry the genetic change and therefore have a very low risk of having another child with Cantú syndrome. Genetic counselling can provide detailed information and support for families concerned about inheritance patterns and future family planning.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosing Cantú syndrome typically involves a combination of clinical evaluation and genetic testing. A healthcare professional may suspect the condition based on the presence of characteristic symptoms like an enlarged heart, skeletal anomalies, excessive hair growth, and distinctive facial features. Imaging studies, such as echocardiograms or X-rays, can help to identify specific cardiac and skeletal abnormalities. Genetic testing, specifically sequencing of the ABCC9 and KCNJ8 genes, is used to confirm the diagnosis. The availability of genomic testing through the NHS Genomic Medicine Service (GMS) means that healthcare providers can refer eligible patients for testing. Genetic testing for Cantú syndrome usually falls under specific NHS R-codes, ensuring a standardised approach to diagnosis. A clinical genetics service or specialist paediatrician would typically initiate the referral for such testing.
Management & lifestyle
Management for individuals with Cantú syndrome is multidisciplinary and focuses on addressing the specific symptoms and complications that arise. This often involves regular monitoring of cardiac function, with interventions such as medication or, in some cases, surgery for patent ductus arteriosus or severe cardiac hypertrophy. Blood pressure may also be monitored and managed, particularly if low blood pressure is a persistent issue. Skeletal anomalies may require orthopaedic assessment and management, and developmental support may be provided as needed. Individuals might also benefit from specialist input from dermatologists for hypertrichosis or lymphoedema specialists. The NHS Genomic Medicine Service provides a pathway for ongoing care, with clinical geneticists and genetic counsellors playing a key role in coordinating specialist referrals and providing family support. Management plans are tailored to each individual's needs and current symptoms.
UK care pathway
In the UK, individuals with suspected Cantú syndrome are generally referred to a clinical genetics service by their GP or specialist. These services are part of the NHS Genomic Medicine Service (GMS) and can arrange for appropriate genetic testing to confirm the diagnosis, guided by relevant NHS R-codes. Once a diagnosis is made, a genetic counsellor will be available to discuss the implications of the condition for the individual and their family, including inheritance patterns and future planning. Care is typically coordinated by a multi-specialist team to address the various clinical needs.
Frequently asked questions
Is Cantú syndrome always severe?
No, the severity of Cantú syndrome can vary significantly. Some individuals may have milder symptoms, while others experience more severe challenges, particularly related to heart health. Management plans are always tailored to the individual's specific needs.
Will my children inherit Cantú syndrome?
Cantú syndrome follows an autosomal dominant inheritance pattern. If you have the condition, each of your children has a 50% chance of inheriting it. If the genetic change in you arose spontaneously (de novo), the risk to your future children is typically very low. Genetic counsellors can provide personalised risk assessments.
What kind of doctors will be involved in my care?
Due to the wide range of symptoms, your care team may include cardiologists for heart issues, orthopaedic specialists for skeletal concerns, and possibly developmental paediatricians. A clinical genetics team will help coordinate your overall care within the NHS.
Is there a cure for Cantú syndrome?
Currently, there is no cure for Cantú syndrome. However, management focuses on treating the specific symptoms and complications to improve quality of life. This can involve medications, therapies, and sometimes surgical interventions, especially for heart conditions.
Can excess hair growth (hypertrichosis) be managed?
Yes, excessive hair growth is a common feature of Cantú syndrome. Various methods can be used to manage hypertrichosis, and a dermatologist or specialist may be able to offer advice on suitable options, which are often cosmetic rather than medical.
References
- Adam MP, Bick S, Mirzaa GM. Cantú Syndrome. 1993. PMID: 25275207
- Davis MJ, Kim HJ, Nichols CG. K(ATP) channels in lymphatic function. American journal of physiology. Cell physiology. 2022. PMID: 35785984
- Nichols CG. Personalized Therapeutics for K(ATP)-Dependent Pathologies. Annual review of pharmacology and toxicology. 2023. PMID: 36170658
- McClenaghan C, Nichols CG. Kir6.1 and SUR2B in Cantú syndrome. American journal of physiology. Cell physiology. 2022. PMID: 35876283
- Marques P, Korbonits M. Approach to the Patient With Pseudoacromegaly. The Journal of clinical endocrinology and metabolism. 2022. PMID: 34792134
- Hamilton MJ, Suri M. "Electrifying dysmorphology": Potassium channelopathies causing dysmorphic syndromes. Advances in genetics. 2020. PMID: 32560786
- Roessler HI, Shields K, Grange DK. Three-dimensional facial morphology in Cantú syndrome. American journal of medical genetics. Part A. 2020. PMID: 32100467
- Aguayo-Orozco TA, Ríos-González BE, Castro-Martínez AG. Generalized hypertrichosis syndromes in Mexico. American journal of medical genetics. Part C, Seminars in medical genetics. 2020. PMID: 33283427